血清尿酸控制不良会增加患高血压的风险:中国的一项回顾性队列研究
Zeyin Lin1, Shaoyan Wu2, Zhe Chen2
1Department of Ultrasound, the First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Frontiers in endocrinology
|February 15, 2024
概括
血清尿酸 (SUA) 控制不良会增加高血压风险,特别是随着时间的推移而上升的水平. 管理SUA对于预防高血压至关重要.
科学领域:
- 心血管医学 心血管医学
- 代谢健康 代谢健康
- 高血压研究 高血压研究
背景情况:
- 血清尿酸 (SUA) 与高血压的发展有关.
- 关于SUA变化对高血压发病率的影响的数据有限.
研究的目的:
- 为了研究血清尿酸 (SUA) 水平,随着时间的推移SUA的变化,以及高血压的发生率之间的联系.
- 探索SUA控制在高血压的初级预防中的作用.
主要方法:
- 分析了6052名在基线没有高血压的参与者的动态队列.
- 参与者根据基线SUA和随时间变化而被分为六个等级.
- 后勤回归和受限立方线 (RCS) 模型被用于评估高血压发病率.
主要成果:
- 在6年内,42.1%的人患上高血压.
- 更糟糕的SUA控制等级与高血压发病率的几率显著增加有关.
- RCS模型揭示了SUA变化与高血压风险之间的线性相关性,基线高尿血症加剧了这种风险.
结论:
- 血清尿酸 (SUA) 控制不良,包括随着时间的推移增加,会增加高血压风险.
- 基线超尿血症进一步增加了这种风险.
- 有效的SUA管理对于高血压的初级预防至关重要.
相关概念视频
Antihypertensive Drugs: Action of Diuretics
694
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
694
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638
Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K


